newsio aggregates and links to original sources. We do not own the original images or content. If you believe content infringes on intellectual property rights, contact us — it will be removed at first notice.

business / news / / Seeking Alpha

Cheap semaglutide copies in India challenge Novo Nordisk, cut Eli Lilly’s lead.

Low-cost semaglutide copies are now widely available in India's obesity drug market.

KEY POINTS
COMPANIES
Read the full story on Seeking Alpha →
Share X LinkedIn

Summarized by Newsio from Seeking Alpha. How we summarize →